Form 4: MaxLinear Director Sells Shares Under 10b5-1 Plan

MaxLinear Director Ted L. Tewksbury III reported transactions involving the sale of common stock and the vesting of restricted stock units.

Summary

• Ted L. Tewksbury III, a Director at MaxLinear, Inc. (MXL), reported several transactions on May 1st, 4th, and 5th, 2026.
• On May 1, 2026, 2,790 shares of common stock were sold at a price of $78.665 per share, resulting in a direct beneficial ownership of 72,205 shares.
• Also on May 1, 2026, 15,741 restricted stock units (RSUs) vested, which are contingent rights to receive one share of common stock. These vested shares were directly owned.
• On May 4, 2026, 3,935 shares were sold at $77.36 per share, reducing direct ownership to 84,011 shares.
• On May 5, 2026, another 3,935 shares were sold at $80 per share, further reducing direct ownership to 80,076 shares.
• All sales were executed under a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the insider selling, despite it being executed under a pre-planned 10b5-1 strategy.

Positives

• The sales were conducted under a pre-established Rule 10b5-1 trading plan, indicating a planned and orderly divestment rather than reactive selling.
• The vesting of 15,741 RSUs on May 1, 2026, signifies the fulfillment of equity compensation awards.

Negatives

• A total of 10,520 shares (2,790 + 3,935 + 3,935) were sold by a director within a short period.
• The sales represent a reduction in direct beneficial ownership by a key insider.

Risks

• Potential for negative market perception due to insider selling, even if conducted under a 10b5-1 plan.
• The sales could be interpreted as a lack of confidence in future stock performance by a company insider.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports past transactions.

Management Comments

• The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on June 2, 2025 by the Reporting Person.
• Each restricted stock unit ('RSU') represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
• One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2026.

Industry Context

StockSavvy.ai notes that insider selling, even under a Rule 10b5-1 plan, is a common event for executives and directors to diversify holdings or meet financial obligations. However, the volume and timing relative to company news can influence market perception.

Stakeholder Impact

• Shareholders: May view insider selling with caution, potentially impacting short-term stock sentiment, though the 10b5-1 plan mitigates concerns about non-public information.
• Employees: May interpret insider sales as a signal about future company performance, though the vesting of RSUs is a positive for those receiving them.
• Management: The transactions reflect standard equity management practices for directors.

Next Steps

• Continued monitoring of insider transactions for any further sales or purchases.
• Analysis of MaxLinear's upcoming financial reports and strategic announcements to contextualize insider activity.

Key Dates

Keywords

MaxLinear, MXL, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Ted L. Tewksbury III, Restricted Stock Units, SEC Filing, Beneficial Ownership